Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial
Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a deployment update without visible changes to content or features.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated to v3.5.3, signaling a minor system update; no changes to study details, enrollment, or other visible content.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No changes to study details or visible content.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2. The change is a site-wide version label visible on the page footer.SummaryDifference0.1%

- Check108 days agoChange DetectedA new page revision tag v3.4.2 is added and a previous funding notice about government operating status is removed. No study content, results, eligibility criteria, enrollment numbers, or navigation elements are altered.SummaryDifference0.5%

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.